10-K Filing

ETHEMA HEALTH CORP CIK: 792935 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001903596-23-000263`
Period End Date	20221231
Filing Date	20230331
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	grst_10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 64 Cash Flow Statement 97 Stockholders Equity 22

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	4.00M	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	4.00M	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$140.76K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$48.82K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$176.01K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$337.07K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	10.00B	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	10.00B	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	3.73B	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$44.72K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$29.73K	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	3.58B	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	3.73B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$17.23K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$20.35K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$271.80K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$542.90K	USD	Point-in-time
Due on sale of subsidiary	`DueOnSaleOfSubsidiary`	-	USD	Point-in-time
Due on sale of subsidiary	`DueOnSaleOfSubsidiary`	$5.12K	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentNet`	$2.97M	USD	Point-in-time
Property and equipment	`PropertyPlantAndEquipmentNet`	$3.01M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$1.25M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$1.61M	USD	Point-in-time
Right of use assets	`OperatingLeaseRightOfUseAsset`	$1.65M	USD	Point-in-time
Right of use assets	`OperatingLeaseRightOfUseAsset`	$1.39M	USD	Point-in-time
Deposits paid	`DepositContractsAssets`	$400.00K	USD	Point-in-time
Deposits paid	`DepositContractsAssets`	-	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$6.28M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$6.02M	USD	Point-in-time
Total assets	`Assets`	$6.55M	USD	Point-in-time
Total assets	`Assets`	$6.56M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$170.93K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$438.48K	USD	Point-in-time
Taxes payable	`AccruedIncomeTaxesCurrent`	$658.84K	USD	Point-in-time
Taxes payable	`AccruedIncomeTaxesCurrent`	$248.64K	USD	Point-in-time
Convertible notes, net of discounts	`ConvertibleDebtCurrent`	$5.27M	USD	Point-in-time
Convertible notes, net of discounts	`ConvertibleDebtCurrent`	$4.89M	USD	Point-in-time
Short-term notes	`ShortTermBorrowings`	$460.53K	USD	Point-in-time
Short-term notes	`ShortTermBorrowings`	$122.17K	USD	Point-in-time
Mortgage loans	`MortgageLoans`	$3.86M	USD	Point-in-time
Mortgage loans	`MortgageLoans`	$3.50M	USD	Point-in-time
Receivables funding	`ReceivablesFunding`	-	USD	Point-in-time
Receivables funding	`ReceivablesFunding`	$416.73K	USD	Point-in-time
Government assistance loans	`FederalAssistanceLoansCurrent`	$157.37K	USD	Point-in-time
Government assistance loans	`FederalAssistanceLoansCurrent`	$14.82K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$287.02K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$241.08K	USD	Point-in-time
Finance lease liability	`FinanceLeaseLiabilityCurrent`	$7.89K	USD	Point-in-time
Finance lease liability	`FinanceLeaseLiabilityCurrent`	$7.39K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$515.90K	USD	Point-in-time
Accrued dividends	`DividendsPayableCurrent`	$194.83K	USD	Point-in-time
Accrued dividends	`DividendsPayableCurrent`	$105.05K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.52M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.29M	USD	Point-in-time
Government assistance loans	`FederalAssistanceLoansNonCurrent`	$47.33K	USD	Point-in-time
Government assistance loans	`FederalAssistanceLoansNonCurrent`	$79.56K	USD	Point-in-time
Deferred taxation	`DeferredIncomeTaxLiabilities`	$217.45K	USD	Point-in-time
Deferred taxation	`DeferredIncomeTaxLiabilities`	$273.06K	USD	Point-in-time
Third party loans	`ThirdPartyLoan`	$578.34K	USD	Point-in-time
Third party loans	`ThirdPartyLoan`	$646.18K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$1.49M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$1.21M	USD	Point-in-time
Finance lease liability	`FinanceLeaseLiabilityNoncurrent`	$24.95K	USD	Point-in-time
Finance lease liability	`FinanceLeaseLiabilityNoncurrent`	$32.90K	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.11M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.49M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.40M	USD	Point-in-time
Total liabilities	`Liabilities`	$16.01M	USD	Point-in-time
Common stock - $0.01 par value, 10,000,000,000 shares authorized; 3,729,053,805 and 3,579,053,805 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively.	`CommonStockValue`	$35.79M	USD	Point-in-time
Common stock - $0.01 par value, 10,000,000,000 shares authorized; 3,729,053,805 and 3,579,053,805 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively.	`CommonStockValue`	$37.29M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.42M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$22.79M	USD	Point-in-time
Discount for shares issued below par value	`DiscountForSharesIssuedBelowParValue`	$-26.01M	USD	Point-in-time
Discount for shares issued below par value	`DiscountForSharesIssuedBelowParValue`	$-27.36M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossBeforeTax1`	$-5.07K	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossBeforeTax1`	$816.53K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-44.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-43.48M	USD	Point-in-time
Stockholders deficit attributable to Ethema Health Corporation stockholders	`StockholdersEquity`	$-10.68M	USD	Point-in-time
Stockholders deficit attributable to Ethema Health Corporation stockholders	`StockholdersEquity`	$-10.10M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$870.18K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$822.88K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.86M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-15.03M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$6.56M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$6.55M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$1.94M	USD	Annual
Revenues	`Revenues`	$4.82M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$805.37K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$531.39K	USD	Annual
Rent expense	`RentExpense`	$427.48K	USD	Annual
Rent expense	`RentExpense`	$178.68K	USD	Annual
Management fees	`ManagementFeeExpense`	$132.50K	USD	Annual
Management fees	`ManagementFeeExpense`	$60.00K	USD	Annual
Professional fees	`ProfessionalFee`	$132.28K	USD	Annual
Professional fees	`ProfessionalFee`	$463.68K	USD	Annual
Salaries and wages	`SalariesAndWages`	$712.79K	USD	Annual
Salaries and wages	`SalariesAndWages`	$1.96M	USD	Annual
Depreciation expense	`DepreciationAndAmortization`	$325.35K	USD	Annual
Depreciation expense	`DepreciationAndAmortization`	$540.12K	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.94M	USD	Annual
Total operating expenses	`OperatingExpenses`	$4.33M	USD	Annual
Operating profit	`OperatingIncomeLoss`	$2.10K	USD	Annual
Operating profit	`OperatingIncomeLoss`	$489.12K	USD	Annual
Other income	`NonoperatingIncomeExpense`	$15.76K	USD	Annual
Other income	`NonoperatingIncomeExpense`	$273.37K	USD	Annual
Forgiveness of government relief loan	`ForgivenessOfGovernmentReliefLoan`	$104.37K	USD	Annual
Forgiveness of government relief loan	`ForgivenessOfGovernmentReliefLoan`	$156.78K	USD	Annual
Loss on advance	`LossOnAdvance`	-	USD	Annual
Loss on advance	`LossOnAdvance`	$120.00K	USD	Annual
Fair value of warrants granted to convertible note holders	`FairValueOfWarrantsGrantedToConvertibleDebtHolder`	$854.14K	USD	Annual
Fair value of warrants granted to convertible note holders	`FairValueOfWarrantsGrantedToConvertibleDebtHolder`	-	USD	Annual
Penalty on notes and convertible notes	`PenaltyOnConvertibleNote`	$-60.08K	USD	Annual
Penalty on notes and convertible notes	`PenaltyOnConvertibleNote`	$-9.24K	USD	Annual
Interest income	`InterestIncomeOther`	-	USD	Annual
Interest income	`InterestIncomeOther`	$78.00	USD	Annual
Interest expense	`InterestExpenseDebtExcludingAmortization`	$588.48K	USD	Annual
Interest expense	`InterestExpenseDebtExcludingAmortization`	$829.52K	USD	Annual
Debt discount	`AmortizationOfDebtDiscountPremium`	$-624.68K	USD	Annual
Debt discount	`AmortizationOfDebtDiscountPremium`	$-1.97M	USD	Annual
Derivative liability movement	`DerivativeGainLossOnDerivativeNet`	$-1.53M	USD	Annual
Derivative liability movement	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Foreign exchange movements	`ForeignExchangeMovements`	$-1.07M	USD	Annual
Foreign exchange movements	`ForeignExchangeMovements`	$34.30K	USD	Annual
Net income (loss) before taxation	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.85M	USD	Annual
Net income (loss) before taxation	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$407.41K	USD	Annual
Taxation	`IncomeTaxExpenseBenefit`	$-112.22K	USD	Annual
Taxation	`IncomeTaxExpenseBenefit`	$280.90K	USD	Annual
Net income (loss)	`IncomeLossFromSubsidiariesNetOfTax`	$295.19K	USD	Annual
Net income (loss)	`IncomeLossFromSubsidiariesNetOfTax`	$-1.57M	USD	Annual
Net (income) loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$30.46K	USD	Annual
Net (income) loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-47.31K	USD	Annual
Net income (loss) attributable to Ethema Health Corporation Stockholders	`NetIncomeLoss`	$-1.54M	USD	Annual
Net income (loss) attributable to Ethema Health Corporation Stockholders	`NetIncomeLoss`	$247.88K	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$100.58K	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$97.78K	USD	Annual
Net income (loss) available to common shareholders of Ethema Health Corporation	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.64M	USD	Annual
Net income (loss) available to common shareholders of Ethema Health Corporation	`NetIncomeLossAvailableToCommonStockholdersBasic`	$150.10K	USD	Annual
Foreign currency translation adjustment	`DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther`	$821.60K	USD	Annual
Foreign currency translation adjustment	`DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther`	$-9.81K	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.63M	USD	Annual
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-671.50K	USD	Annual
Basic income (loss) per common share	`BasicLossIncomePerCommonShare`	-	USD	Annual
Basic income (loss) per common share	`BasicLossIncomePerCommonShare`	-	USD	Annual
Diluted income (loss) per common share	`DilutedLossIncomePerCommonShare`	-	USD	Annual
Diluted income (loss) per common share	`DilutedLossIncomePerCommonShare`	-	USD	Annual
Weighted average common shares outstanding Basic	`WeightedAverageCommonSharesOutstandingBasic`	3.70B	shares	Annual
Weighted average common shares outstanding Basic	`WeightedAverageCommonSharesOutstandingBasic`	2.70B	shares	Annual
Weighted average common shares outstanding Diluted	`WeightedAverageCommonSharesOutstandingDiluted`	4.28B	shares	Annual
Weighted average common shares outstanding Diluted	`WeightedAverageCommonSharesOutstandingDiluted`	2.70B	shares	Annual

Cash Flow Statement 97 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-1.57M	USD	Annual
Net income (loss)	`ProfitLoss`	$295.19K	USD	Annual
Net cash from sale of subsidiary	`IncreaseDecreaseInTimeDeposits`	$1.42K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$325.35K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$540.12K	USD	Annual
Forgiveness of federal relief loan	`ForgivenessOfGovernmentReliefLoan`	$104.37K	USD	Annual
Forgiveness of federal relief loan	`ForgivenessOfGovernmentReliefLoan`	$156.78K	USD	Annual
Amortization of debt discount	`OtherAmortizationOfDeferredCharges`	$624.68K	USD	Annual
Amortization of debt discount	`OtherAmortizationOfDeferredCharges`	$1.96M	USD	Annual
Penalty on promissory notes	`PenaltyOnPromissoryNotes`	$60.08K	USD	Annual
Penalty on promissory notes	`PenaltyOnPromissoryNotes`	-	USD	Annual
Derivative liability movements	`DerivativeLiabilityMovements`	$1.53M	USD	Annual
Derivative liability movements	`DerivativeLiabilityMovements`	-	USD	Annual
Non-cash interest converted to equity	`NoncashInterestConvertedToEquity`	-	USD	Annual
Non-cash interest converted to equity	`NoncashInterestConvertedToEquity`	$90.14K	USD	Annual
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$118.75K	USD	Annual
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$260.75K	USD	Annual
Deferred taxation movement	`DeferredTaxationMovement`	$-55.61K	USD	Annual
Deferred taxation movement	`DeferredTaxationMovement`	$-37.59K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-4.27K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$215.36K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-15.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$10.46K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$114.70K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-3.11K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$25.11K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$305.79K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-101.64K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-241.08K	USD	Annual
Taxes payable	`IncreaseDecreaseInAccruedTaxesPayable`	$-193.44K	USD	Annual
Taxes payable	`IncreaseDecreaseInAccruedTaxesPayable`	$125.01K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.58M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-85.57K	USD	Annual
Acquisition of subsidiary, net of cash	`PaymentsToAcquireBusinessesAndInterestInAffiliates`	-	USD	Annual
Acquisition of subsidiary, net of cash	`PaymentsToAcquireBusinessesAndInterestInAffiliates`	$10.32K	USD	Annual
Proceeds from deposits	`ProceedsFromOtherDeposits`	$4.98K	USD	Annual
Proceeds from deposits	`ProceedsFromOtherDeposits`	-	USD	Annual
Investment in deposits	`PaymentsToAcquireRestrictedCertificatesOfDeposit`	-	USD	Annual
Investment in deposits	`PaymentsToAcquireRestrictedCertificatesOfDeposit`	$400.00K	USD	Annual
Other investments	`PaymentsToAcquireOtherInvestments`	$450.54K	USD	Annual
Other investments	`PaymentsToAcquireOtherInvestments`	-	USD	Annual
Purchase of property and equipment	`PaymentsToAcquireProductiveAssets`	$132.83K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquireProductiveAssets`	$315.82K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-712.26K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-573.04K	USD	Annual
Repayment of mortgage	`RepaymentOfMortgage`	$-117.07K	USD	Annual
Repayment of mortgage	`RepaymentOfMortgage`	$-117.52K	USD	Annual
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$1.23M	USD	Annual
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$499.54K	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Proceeds from promissory notes	`ProceedsFromUnsecuredNotesPayable`	$160.00K	USD	Annual
Proceeds from promissory notes	`ProceedsFromUnsecuredNotesPayable`	$420.45K	USD	Annual
Repayment of promissory notes	`RepaymentsOfNotesPayable`	$464.34K	USD	Annual
Repayment of promissory notes	`RepaymentsOfNotesPayable`	$289.04K	USD	Annual
Proceeds from receivables funding	`ProceedsFromReceivablesFunding`	-	USD	Annual
Proceeds from receivables funding	`ProceedsFromReceivablesFunding`	$682.50K	USD	Annual
Repayment of receivables funding	`RepaymentOfReceivablesFunding`	-	USD	Annual
Repayment of receivables funding	`RepaymentOfReceivablesFunding`	$330.31K	USD	Annual
Proceeds from government assistance loans	`ProceedsFromGovernmentAssistanceLoans`	$173.32K	USD	Annual
Proceeds from government assistance loans	`ProceedsFromGovernmentAssistanceLoans`	-	USD	Annual
Repayment of government assistance loans	`RepaymentOfGovernmentAssistanceLoans`	-	USD	Annual
Repayment of government assistance loans	`RepaymentOfGovernmentAssistanceLoans`	$-2.97K	USD	Annual
Preferred stock dividends paid	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$24.00K	USD	Annual
Preferred stock dividends paid	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	Annual
Repayment of third party loans	`RepaymentsOfOtherDebt`	$76.86K	USD	Annual
Repayment of third party loans	`RepaymentsOfOtherDebt`	$127.64K	USD	Annual
Proceeds from finance leases	`ProceedsFromFinanceLeases`	$43.45K	USD	Annual
Proceeds from finance leases	`ProceedsFromFinanceLeases`	-	USD	Annual
Repayment of finance leases	`RepaymentOfFinanceLeases`	$3.17K	USD	Annual
Repayment of finance leases	`RepaymentOfFinanceLeases`	$7.44K	USD	Annual
Proceeds (repayment) of related party notes	`RepaymentProceedsFromRelatedPartyNotes`	$284.91K	USD	Annual
Proceeds (repayment) of related party notes	`RepaymentProceedsFromRelatedPartyNotes`	$-43.52K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$303.71K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$590.20K	USD	Annual
Effect of exchange rate on cash	`EffectOfExchangesRateOnCash`	$-1.08M	USD	Annual
Effect of exchange rate on cash	`EffectOfExchangesRateOnCash`	$26.74K	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$91.94K	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-41.68K	USD	Annual
Beginning cash balance	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.76K	USD	Point-in-time
Beginning cash balance	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$48.82K	USD	Point-in-time
Beginning cash balance	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.50K	USD	Point-in-time
Ending cash balance	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$140.76K	USD	Point-in-time
Ending cash balance	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$48.82K	USD	Point-in-time
Ending cash balance	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.50K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$281.15K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$234.24K	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Fair value of warrant issued	`FairValueOfWarrantIssued`	-	USD	Annual
Fair value of warrant issued	`FairValueOfWarrantIssued`	$1.76M	USD	Annual
Shares issued in consideration of acquisition of subsidiary	`SharesIssuedInConsiderationOfAcquisition`	$410.00K	USD	Annual
Shares issued in consideration of acquisition of subsidiary	`SharesIssuedInConsiderationOfAcquisition`	-	USD	Annual
Conversion of convertible notes	`ConversionOfConvertibleNotes`	$4.12M	USD	Annual
Conversion of convertible notes	`ConversionOfConvertibleNotes`	$150.00K	USD	Annual
Fair value of non-controlling interest	`MinorityInterestPeriodIncreaseDecrease`	-	USD	Annual
Fair value of non-controlling interest	`MinorityInterestPeriodIncreaseDecrease`	$153.33K	USD	Annual

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.86M	USD	Point-in-time
Beginning balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-15.03M	USD	Point-in-time
Beginning balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time
Warrants exercised	`WarrantsExercised`	-	USD	Annual
Shares issued in consideration of acquisition of subsidiary	`StockIssuedDuringPeriodValueAcquisitions`	$410.00K	USD	Annual
Fair value of non-controlling interest on acquisition of subsidiary	`FairValueOfNoncontrollingInterestOnAcquisitionOfSubsidiary`	$153.33K	USD	Annual
Conversion of convertible notes	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.12M	USD	Annual
Conversion of convertible notes	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$150.00K	USD	Annual
Fair value of warrants issued to convertible debt holders	`FairValueOfWarrantsIssued`	$1.76M	USD	Annual
Fair value of beneficial conversion feature of convertible debt issued	`FairValueOfBeneficialConversionFeatureOfConvertibleDebtIssued`	$133.75K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent`	$-821.60K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent`	$9.81K	USD	Annual
Transactions with related parties	`RelatedPartyTransactionAmountsOfTransaction`	$259.71K	USD	Annual
Transactions with related parties	`RelatedPartyTransactionAmountsOfTransaction`	$628.57K	USD	Annual
Net income	`ProfitLoss`	$-1.57M	USD	Annual
Net income	`ProfitLoss`	$295.19K	USD	Annual
Dividends accrued	`DividendsAccrued`	$-97.78K	USD	Annual
Dividends accrued	`DividendsAccrued`	$-100.58K	USD	Annual
Adjustments to prior period on adoption of ASU 2020-06	`AdjustmentsToPriorPeriodOnAdoptionOfASU`	$468.46K	USD	Annual
Ending balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.86M	USD	Point-in-time
Ending balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-15.03M	USD	Point-in-time
Ending balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.